Pinnacle Bancorp, Inc. Charles River Laboratories International, Inc. Transaction History
Pinnacle Bancorp, Inc.
- $318 Million
- Q2 2025
A detailed history of Pinnacle Bancorp, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 190 shares of CRL stock, worth $33,616. This represents 0.01% of its overall portfolio holdings.
Number of Shares
190
Previous 190
-0.0%
Holding current value
$33,616
Previous $28,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding CRL
# of Institutions
624Shares Held
54.9MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$900 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$758 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$423 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$405 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...